medline.ch Onkologie

	Hypoxia-mediated cancer stem cell resistance and targeted therapy. Biomed Pharmacother Sun X, Lv X, Yan Y, Zhao Y, Ma R, He M, Wei M. PMID: 32791395 [PubMed - as supplied by publisher]
	Traditional Chinese exercise for cancer-related sleep disturbance: A systematic review and descriptive analysis of randomized controlled trials. Complement Ther Clin Pract Yao LQ, Tan JY, Turner C, Wang T, Liu XL. PMID: 32791319 [PubMed - as supplied by publisher]
	The remaining ipsilateral ureteral orifice provokes intravesical tumor recurrence after nephroureterectomy for upper tract urothelial carcinoma: A multicenter study with a mid-term follow-up. Urology Kwon SY, Ko YH, Song PH, Kim BH, Kim BS, Kim TH, KYUS group.. PMID: 32791287 [PubMed - as supplied by publisher]
	Lipids in the tumor microenvironment: From cancer progression to treatment. Prog Lipid Res Corn KC, Windham MA, Rafat M. PMID: 32791170 [PubMed - as supplied by publisher]
	Mechanisms of cancer stem cell therapy. Clin Chim Acta Akbar Samadani A, Keymoradzdeh A, Shams S, Soleymanpour A, Elham Norollahi S, Vahidi S, Rashidy-Pour A, Ashraf A, Mirzajani E, Khanaki K, Rahbar Taramsari M, Samimian S, Najafzadeh A. PMID: 32791136 [PubMed - as supplied by publisher]
	Association between Hydrochlorothiazide and the Risk of In-situ and Invasive Squamous Cell Skin Carcinoma and Basal Cell Carcinoma: A Population-Based Case-Control Study. J Am Acad Dermatol Adalsteinsson JA, Muzumdar S, Waldman R, Hu C, Wu R, Ratner D, Ungar J, Silverberg JI, Olafsdottir GH, Kristjansson AK, Tryggvadottir L, Jonasson J. PMID: 32791082 [PubMed - as supplied by publisher]
	CAR T-cell therapy for cancer and HIV through novel approaches to HIV-associated haematological malignancies. Lancet Haematol Rust BJ, Kiem HP, Uldrick TS. PMID: 32791043 [PubMed - as supplied by publisher]
	Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT. Cancer Biol Ther Handy WF, Schmidt KT, Price DK, Figg WD. PMID: 32791030 [PubMed - as supplied by publisher]
	The Impact of a Ketogenic Dietary Intervention on the Quality of Life of Stage II and III Cancer Patients: A Randomized Controlled Trial in the Caribbean. Nutr Cancer Augustus E, Granderson I, Rocke KD. PMID: 32791011 [PubMed - as supplied by publisher]
	Novel insights into the function of CD24: a driving force in cancer. Int J Cancer Altevogt P, Sammar M, Hüser L, Kristiansen G. PMID: 32790899 [PubMed - as supplied by publisher]
	Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma. PLoS One Fukuda H, Sato D, Moriwaki K, Ishida H. PMID: 32790706 [PubMed - as supplied by publisher]
	Mutations in m6A consensus motifs are suppressed in the m6A modified genes in human cancer cells. PLoS One An M, Wang H, Zhu Y. PMID: 32790688 [PubMed - as supplied by publisher]
	Multi-stage feature selection (MSFS) algorithm for UWB-based early breast cancer size prediction. PLoS One Vijayasarveswari V, Andrew AM, Jusoh M, Sabapathy T, Raof RAA, Yasin MNM, Ahmad RB, Khatun S, Rahim HA. PMID: 32790672 [PubMed - as supplied by publisher]
	Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer. Acta Oncol Hermunen K, Soveri LM, Boisen MK, Mustonen HK, Dehlendorff C, Haglund CH, Johansen JS, Osterlund P. PMID: 32790589 [PubMed - as supplied by publisher]
	MicroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review. J Int Med Res Wei XY, Ding J, Tian WG, Yu YC. PMID: 32790532 [PubMed - as supplied by publisher]
	PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline. J Clin Oncol Tew WP, Lacchetti C, Ellis A, Maxian K, Banerjee S, Bookman M, Jones MB, Lee JM, Lheureux S, Liu JF, Moore KN, Muller C, Rodriguez P, Walsh C, Westin SN, Kohn EC. PMID: 32790492 [PubMed - as supplied by publisher]
	Engineering Nanoparticles toward the Modulation of Emerging Cancer Immunotherapy. Adv Healthc Mater Wang S, Sun Z, Hou Y. PMID: 32790039 [PubMed - as supplied by publisher]
	Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer. Oncologist Garje R, An J, Obeidat M, Kumar K, Yasin HA, Zakharia Y. PMID: 32790011 [PubMed - as supplied by publisher]
	Cabozantinib in advanced renal cell carcinoma: A phaseÂ II, open-label, single-arm study of Japanese patients. Int J Urol Tomita Y, Tatsugami K, Nakaigawa N, Osawa T, Oya M, Kanayama H, Nakayama Kondoh C, Sassa N, Nishimura K, Nozawa M, Masumori N, Miyoshi Y, Kuroda S, Tanaka S, Kimura A, Tamada S. PMID: 32789967 [PubMed - as supplied by publisher]
	Metastatic breast cancer diagnosed on cervical cytology. Cytopathology Yuan L, Oshilaja O, Sierk A, Zhang G, Booth CN, Brainard J, Dyhdalo KS. PMID: 32789952 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 1372808

Seite 1 von 68641

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung